GeneDx Holdings Corp. Class A Common Stock (WGS)

About WGS

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx H…

Sector

Technology

Industry

Retail: Computer Software & Peripheral Equipment

Employees

1,300

Website

sema4.com/

Fundamentals

1-day range

$85.93$89.65

Market cap

$2.01B

P/E (trailing)

—

P/E (forward)

73.87

EPS (trailing)

$-3.63

Dividend yield

—

Beta

2.00

Avg. volume

867.6K

Forecasts

9 analyst ratings

GeneDx Holdings Corp. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• WGS

  GeneDx Holdings Corp. Class A Common Stock

  $86.38

  ▼ 3.20%
  Market cap $2.01BP/E —
  $32.21$170.87
• PLUS

  ePlus inc. Common Stock

  $87.07

  ▼ 0.68%
  Market cap $2.62BP/E 18.56
  $69.07$98.14
• CGTL

  Creative Global Technology Holdings Limited Class A Ordinary Shares

  $4.26

  ▼ 4.91%
  Market cap $7.20MP/E —
  $2.27$96
• INGM

  Ingram Micro Holding Corporation Common Stock

  $28.76

  ▼ 1.81%
  Market cap $6.44BP/E 15.18
  $18.77$31.69
• SNX

  TD SYNNEX Corporation Common Stock

  $254.03

  ▼ 2.35%
  Market cap $20.30BP/E 18.11
  $142.22$296.47

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• GeneDx Announces New Data Published In Genetics In Medicine Demonstrating First‑Tier Rapid Genome Sequencing Improves Diagnostic Rates, Patient Outcomes, And Operational Efficiency In Pediatric Care
  benzinga · 8/24/2026
• GeneDx: Why I Think The Worst Is Behind The Business
  SeekingAlpha · 8/18/2026
• Alger Small Cap Focus Fund Q2 2026 Portfolio Review
  SeekingAlpha · 8/6/2026
• Canaccord Genuity Maintains Buy on GeneDx Holdings, Raises Price Target to $90
  Benzinga · 8/4/2026
• BTIG Reiterates Buy on GeneDx Holdings, Maintains $90 Price Target
  Benzinga · 8/4/2026
• GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ...
  Yahoo · 8/4/2026
• GeneDx Holdings (NASDAQ:WGS) Beats Q2 Revenue Estimates and Swings to Adjusted Profit
  ChartMill · 8/3/2026
• GeneDx Q2 Earnings Call Highlights
  Yahoo · 8/3/2026
• GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates
  Yahoo · 8/3/2026

• GARDNER MARK A · June 29, 2026 · Grant

  35.4K
• Fuchs Thomas · June 18, 2026 · Grant

  4.2K
• Joshua Ruch · June 18, 2026 · Option Exercise

  3.6K
• Joshua Ruch · June 18, 2026 · Grant

  4.2K
• Emily M. Leproust · June 18, 2026 · Option Exercise

  3.6K
• Emily M. Leproust · June 18, 2026 · Grant

  4.2K
• Jason Ryan · June 18, 2026 · Option Exercise

  3.6K
• Eli Casdin · June 18, 2026 · Option Exercise

  3.6K
• Eli Casdin · June 18, 2026 · Grant

  4.2K
• Keith A. Meister · June 18, 2026 · Option Exercise

  3.6K
• Keith A. Meister · June 18, 2026 · Grant

  4.2K
• Richard C. Pfenniger Jr. · June 18, 2026 · Option Exercise

  3.6K
• Richard C. Pfenniger Jr. · June 18, 2026 · Grant

  4.2K
• Kevin Feeley · June 9, 2026 · Option Exercise

  2.5K
• Kevin Feeley · June 9, 2026 · Sale

  1.3K @ $53.77

Institutional Ownership

March 31, 2026

Total shares held

31.47M

Total value held

$2.00B

Institutional holders

237